Td Waterhouse Canada Inc. Aadi Bioscience, Inc. Call Options Transaction History
Td Waterhouse Canada Inc.
- $12.4 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.5MCall Options Held
23.8KPut Options Held
0-
Avoro Capital Advisors LLC New York, NY2.85MShares$7.38 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$5.99 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$5.44 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.79 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$2.97 Million1.96% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $54.4M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...